Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma

S P Leong1, E Donegan, W Heffernon

  • 1Department of Surgery, University of California/Mount Zion Medical Center, San Francisco 94143-1674, USA. leongs@surgery.ucsf.edu

Abstract

Insights

Adverse reactions to isosulfan blue dye during melanoma surgery are rare but serious. This study highlights three cases of anaphylaxis, emphasizing the need for prompt recognition and treatment in operating rooms.

Area of Science:

  • Oncology
  • Surgical Pathology
  • Clinical Immunology

Background:

  • Selective sentinel lymph node (SLN) dissection spares patients from extensive surgery.
  • SLN identification uses isosulfan blue dye or radiocolloid injection.
  • Melanoma staging relies on accurate SLN assessment.

Observation:

  • Three cases of anaphylaxis occurred in 406 patients undergoing SLN mapping.
  • Isosulfan blue dye was administered intradermally around the primary melanoma.
  • Reactions ranged from hypotension to cardiovascular collapse.

Findings:

  • The incidence of anaphylaxis to isosulfan blue was approximately 1%.
  • Anaphylaxis symptoms included urticaria, erythema, hypotension, and bronchospasm.
  • Severity of anaphylaxis varied significantly among affected patients.

Implications:

  • Awareness of isosulfan blue's anaphylactic potential is crucial for surgical teams.
  • Rapid recognition and treatment of anaphylaxis are vital to prevent fatalities.
  • Standardized protocols for managing isosulfan blue-induced anaphylaxis should be implemented.

Related Concept Videos